323 related articles for article (PubMed ID: 31196459)
1. Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review.
Kiuchi MG; Esler MD; Fink GD; Osborn JW; Banek CT; Böhm M; Denton KM; DiBona GF; Everett TH; Grassi G; Katholi RE; Knuepfer MM; Kopp UC; Lefer DJ; Lohmeier TE; May CN; Mahfoud F; Paton JFR; Schmieder RE; Pellegrino PR; Sharabi Y; Schlaich MP
J Am Coll Cardiol; 2019 Jun; 73(23):3006-3017. PubMed ID: 31196459
[TBL] [Abstract][Full Text] [Related]
2. Hypertension: Further EnligHTNment on renal sympathetic denervation.
Mearns BM
Nat Rev Cardiol; 2013 Sep; 10(9):490. PubMed ID: 23836279
[No Abstract] [Full Text] [Related]
3. Renal sympathetic denervation and daily life blood pressure in resistant hypertension: simplicity or complexity?
Parati G; Ochoa JE; Bilo G
Circulation; 2013 Jul; 128(4):315-7. PubMed ID: 23780577
[No Abstract] [Full Text] [Related]
4. Response to letter regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2014 May; 129(20):e500-1. PubMed ID: 24842939
[No Abstract] [Full Text] [Related]
5. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
[TBL] [Abstract][Full Text] [Related]
6. Letter by Jin et al regarding article, "ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension".
Jin Y; Persu A; Staessen JA
Circulation; 2014 May; 129(20):e499. PubMed ID: 24842938
[No Abstract] [Full Text] [Related]
7. Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.
Fengler K; Rommel KP; Hoellriegel R; Blazek S; Besler C; Desch S; Schuler G; Linke A; Lurz P
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515119
[TBL] [Abstract][Full Text] [Related]
8. Renal denervation: what next?
Joyner MJ
Hypertension; 2014 Jul; 64(1):19-20. PubMed ID: 24732888
[No Abstract] [Full Text] [Related]
9. Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success.
Saxena M; Shour T; Shah M; Wolff CB; Julu POO; Kapil V; Collier DJ; Ng FL; Gupta A; Balawon A; Pheby J; Zak A; Rull G; O'Brien B; Schmieder RE; Lobo MD
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29895590
[TBL] [Abstract][Full Text] [Related]
10. Renal denervation in hypertension: Towards a true revival?
Courand PY; Azizi M; Lantelme P
Arch Cardiovasc Dis; 2018 Oct; 111(10):541-544. PubMed ID: 30219622
[No Abstract] [Full Text] [Related]
11. Renal denervation in treatment-resistant hypertension: the need for restraint and more and better evidence.
Persu A; Renkin J; Asayama K; O'Brien E; Staessen JA
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):739-49. PubMed ID: 23750683
[TBL] [Abstract][Full Text] [Related]
12. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
[TBL] [Abstract][Full Text] [Related]
13. Renal denervation: current implications and future perspectives.
Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
[TBL] [Abstract][Full Text] [Related]
14. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
[TBL] [Abstract][Full Text] [Related]
15. Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation.
Esler MD; Osborn JW; Schlaich MP
Hypertension; 2024 Jun; 81(6):1194-1205. PubMed ID: 38557153
[TBL] [Abstract][Full Text] [Related]
16. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
17. Ambulatory blood pressure may be designed as the primary efficacy outcome in clinical trials on renal denervation.
Wang Y
Int J Cardiol; 2014 Oct; 176(3):1262-3. PubMed ID: 25115259
[No Abstract] [Full Text] [Related]
18. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Renal Sympathetic Vasomotion as a Novel End Point for Renal Denervation.
Pellegrino PR; Zucker IH; Chatzizisis YS; Wang HJ; Schiller AM
Hypertension; 2020 Oct; 76(4):1247-1255. PubMed ID: 32829663
[TBL] [Abstract][Full Text] [Related]
20. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
Esler M
J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
